ICAM1 and COVID-19: The findings from this investigation unveiled heightened plasma levels of key proinflammatory cytokines, including interleukin IL-1β, IL-6, TNF-α, monocyte chemoattractant protein-1, and soluble intercellular adhesion molecule-1 in COVID-19 patients.